Pulmonary sarcoidosis induced by the anti-PD-1 monoclonal antibody pembrolizumab or post-immunotherapy granulomatous reaction: which is more appropriate terminology?
ANNALS OF ONCOLOGY, cilt.27, sa.8, ss.1650-1651, 2016 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Kısa Makale
- Cilt numarası: 27 Sayı: 8
- Basım Tarihi: 2016
- Doi Numarası: 10.1093/annonc/mdw193
- Dergi Adı: ANNALS OF ONCOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1650-1651
- Çukurova Üniversitesi Adresli: Evet
Özet
Granulomatous reaction developing after immunotherapy must not be named as sarcoidosis, post-immunotherapy granulomatous reaction is more approprite in cases receiving immunotherapy.